Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-13

Clinical Trial Update: Pivotal Study of the SUpira System in Patients Undergoing High-Risk Percutaneous COronaRy InTervention (HRPCI) [NA]

View source ↗

Summary

A pivotal clinical trial evaluating the SUpira System for patients undergoing high-risk percutaneous coronary intervention in coronary artery disease is current…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SUpira System

Snippet

Sponsor: Supira Medical | Conditions: Coronary Artery Disease, High Risk Percutaneous Coronary Intervention | NA | Status: NOT_YET_RECRUITING